FZD9 and non-small cell lung carcinoma: miR-31 indirectly affects FZD9 expression to mediate the effects of prostacyclin and CSC exposure in human bronchial epithelial cells (HBEC), non-small cell lung cancer (NSCLC) cell lines, and mice10.